Environmental

No disclosed R&D intensity or capital-allocation environmental metrics are provided, limiting evidence of peer-leading resource efficiency versus biotech peers.

Zero reported gross profit margin and absent FCF data do not directly indicate environmental performance, but they constrain visibility into sustainability-related operating discipline versus peers.

The available metrics show no explicit emissions, energy, or waste disclosures, leaving IMNN’s environmental risk profile less transparent than better-disclosed peers.

With no Tier 1 environmental disclosures supplied, the company appears neither advantaged nor clearly disadvantaged on material environmental factors relative to peers.

Social

No workforce, safety, clinical-trial, or patient-access disclosures are provided, so IMNN cannot be assessed as stronger than peers on core biotech social metrics.

Zero stock-based compensation to revenue suggests limited dilution pressure, but it does not substitute for evidence of stronger employee alignment or retention versus peers.

The absence of disclosed social KPIs, such as diversity, turnover, or trial governance, reduces transparency relative to better-reporting peers in the sector.

Based on the supplied data, IMNN shows no clear social advantage or structural weakness versus peers, leaving its positioning broadly average.

Governance

Debt-to-equity of 1.87 is elevated for a development-stage biotech, which can increase governance scrutiny versus less levered peers.

Net debt to EBITDA is negative at -0.07, indicating limited near-term leverage pressure, but this does not offset the higher balance-sheet complexity versus peers.

Zero stock-based compensation to revenue is a favorable signal for capital discipline, yet the absence of board, audit, or ownership disclosures limits stronger governance confidence.

Overall governance appears mixed: financing structure is somewhat more complex than peers, while compensation intensity looks restrained and no major controversy is provided.

Overall Score

IMNN’s ESG positioning is broadly average versus peers because the supplied data show limited disclosure depth and no clear structural advantage across material ESG factors.

Score Driver: Limited ESG Disclosure And Only Mixed Governance Signals Versus Peers.